Published research exists for ingredients in this formula — see Related research below. Whether this product’s doses match those studies could not be confirmed.

Ashwagandha Gummies – 120 Count
Marketing check: 1 remains partly or independently unverified.
Rebuilt from public sources on July 23, 2026 · evidence availability is not a safety or effectiveness verdict.
Does the marketing hold up?
Couldn’t verify means public proof was not found; it is not a mark against the product. Ingredient research is not treated as a trial of this exact product.
◐Partly confirmed1
Marketing language, not scored
ADVANCED FORMULA
What is worth knowing.
Headlines first. Open evidence only when you want the source trail.
Declared contents barely fit the format’s physics
The declared contents leave too little room for the serving itself, or exceed its stated mass. At least one label number needs an explanation.
Evidence and sources
Declared contents total at least 5.1 g per 4-gummy serving: 2.1 g of major actives plus 3 g carbohydrate. A typical pectin gummy is assumed here to weigh 2.5–3.5 g, making a 4-gummy serving roughly 10–14 g. The panel does not state serving weight, so this remains a warning: the d…
Locked evidence record →Open the full source-linked findingA lot of reviews for how new this brand is
The sales implied by the review count are worth weighing against how new or little-known the brand is. This is a plausibility question, not a fake-review verdict.
Evidence and sources
681 ratings, at a typical 1–2% review rate, implies roughly 34,050–68,100 units sold — for a brand about 12 months old. Worth weighing whether that pace is plausible for a new, unknown label. The count is a documented fact; the conclusion is yours.
Locked evidence record →Open the full source-linked findingReviews accumulated gradually
Gradual growth is more ordinary; a sudden burst deserves a closer look. Neither pattern proves whether individual reviews are genuine.
Evidence and sources
Written reviews grew from 28 to 208 across 2026-05-13 – 2026-07-13 with no single manufactured spike (largest 30-day gain ~160).
Locked evidence record →Open the full source-linked findingShow the exact filed address in the full report
8а, Onore de Balzaka Street, Kyiv, 02225, UKRAINEUSPTO identifies the public owner or applicant behind this brand wordmark. This does not by itself identify the product manufacturer or prove where the product was made. Open USPTO source ↗
Dose and research context
Ingredient context used alongside the captured panel. These sources do not test this product or establish safety or effectiveness.
2 g declared
The panel declares 2 g per serving, in the 200–420 mg/day context cited in the research.
Where you can check or buy it
Only the submitted seller page is identity-certain. Other destinations are shown as leads until a shared UPC/GTIN confirms the exact product.
Amazon
Submitted listingExact page checked on 2026-07-21.
View on Amazon ↗Walmart
Not confirmedNo matching product page was confirmed in the current record. Search results cannot be attached as this product until the UPC/GTIN matches.
Search Walmart ↗iHerb
Not confirmedNo matching product page was confirmed in the current record. Search results cannot be attached as this product until the UPC/GTIN matches.
Search iHerb ↗Prices and stock are point-in-time observations. Related pages are never used as product evidence. No affiliate links; LookCloser earns nothing from these sellers.
Want the complete evidence trail?
The summary stops at product-specific facts. The full report preserves every source, calculation, limitation, and unresolved check for review or sharing.
Open the full evidence trailSources, edge cases, and every unresolved check
Confirmed evidence
What checked out02
These checks found support in the public record. They confirm specific facts, not the product as a whole.
Exact trademark owner identified
USPTO lists Maksim Valachenko (INDIVIDUAL) in Ukraine for the exact brand wordmark. This identifies the USPTO mark owner or applicant; it does not by itself prove who manufactures or sells this product.
Reviews accumulated gradually
Written reviews grew from 28 to 208 across 2026-05-13 – 2026-07-13 with no single manufactured spike (largest 30-day gain ~160).
Documented concerns
What needs caution02
These are documented contradictions or claims that need more evidence. They are separate from missing data.
Declared contents barely fit the format’s physics
Declared contents total at least 5.1 g per 4-gummy serving: 2.1 g of major actives plus 3 g carbohydrate. A typical pectin gummy is assumed here to weigh 2.5–3.5 g, making a 4-gummy serving roughly 10–14 g. The panel does not state serving weight, so this remains a warning: the declared contents barely fit the format’s physics. The 2.5–3.5 g gummy assumption is not a measurement.
A lot of reviews for how new this brand is
681 ratings, at a typical 1–2% review rate, implies roughly 34,050–68,100 units sold — for a brand about 12 months old. Worth weighing whether that pace is plausible for a new, unknown label. The count is a documented fact; the conclusion is yours.
Unresolved public record
What is still missing03
We looked for these signals but could not settle them from public sources. A gap is not a strike.
Multi-ingredient formula — panel read, serving weight unknown
We read the full Supplement Facts panel from the listing-image panel (below), but the label doesn’t state a serving weight, so the arithmetic can’t run. A gap in the label’s information, not evidence of a problem.
Research context is available for the listed ingredients
Published sources describe how magnesium, ashwagandha, zinc have been studied. This is ingredient context only; the record does not establish that this product delivers the studied dose or outcome. Sources: NIH ODS — Magnesium fact sheet, PubMed search: magnesium glycinate supplementation.
180-day review-count history is on file
Exact-listing history records written-review counts from 28 on 2026-05-13 to 208 on 2026-07-13 (net +180). Count movements can reflect sales, listing variants, collection resets, or moderation; this history does not establish whether reviews are authentic.
What to ask and check
What would settle the open questions
Why is this shown?
Ask the brand or seller
Answered by the panel: the 2 g listing number equals Zinc (as Zinc Citrate) 5 mg + Ashwagandha Root Extract (10:1)(Withania somnifera)(Root) [Solvent: Water] 2 g. What lot-specific document confirms those declared amounts?
The panel resolves what the headline number includes. The remaining question is whether the product in hand matches those declared amounts; ask for a lot-specific certificate of analysis.
What is the product’s UPC or GTIN?
The barcode is how a product gets matched to outside records — certification registries, label databases, recall data. Without it, almost nothing can be cross-checked.
Is this label filed with NIH’s Dietary Supplement Label Database (DSLD)?
Filing is voluntary, so absence proves nothing — but a filed label puts the full ingredient table on public record where anyone can read it.
Most brands and sellers publish a contact route. A clear answer adds evidence to the record; no answer leaves the question open.
Check for yourself — no one’s permission needed
Compare the panel on the bottle in your hand to the one shown in this record.
Ours was read from listing photos and can contain reading errors. The physical label is the source of truth — if they disagree, tell us and we’ll correct the record.
Check the lot number and expiry on the bottle against any COA you’re given.
A certificate that doesn’t name your lot doesn’t describe what you’re holding.
These are the open questions on this specific record — not a warning about the product, and not a suggestion to buy or avoid it. Getting them answered is how you decide for yourself.
Record built July 23, 2026. Sources: source listing observed at check time · USPTO Trademark Search · Keepa exact-listing history · NIH / published research · certification and regulator records where available. LookCloser publishes evidence and gaps; it does not advise for or against any supplement. Evidence-based corrections welcome.